$FOLD Company News Apple sets intraday record; PetSmart

New Post Public Reply Private Reply Replies (0) Message Board

Aug 29, 2014 at 10:52 AM

$FOLD Company News

Apple sets intraday record; PetSmart considers sale 1:56 p.m. Aug. 20, 2014 - Ben Eisen
Amicus Therapeutics shares up 25.6% in premarket trade 8:05 a.m. Aug. 20, 2014 - Ciara Linnane
Amicus Therapeutic’s Fabry treatment meets goals in late-stage trial 8:04 a.m. Aug. 20, 2014 - Michael Calia
U.S. stocks rise as risk appetite returns 5:19 p.m. April 29, 2014 - Anora Mahmudova
Twitter rallies ahead of earnings; 3D Systems retreats 3:49 p.m. April 29, 2014 - Sue Chang
U.S. stock futures climb; House prices flat in February 9:19 a.m. April 29, 2014 - Barbara Kollmeyer
Amicus rallies 52% premarket after positive trial results 7:25 a.m. April 29, 2014 - Sara Sjolin
Amicus rallies 52% premarket after positive trial results 7:08 a.m. April 29, 2014 - Sara Sjolin
Amicus stock down after it delays seeking Fabry OK 10:44 a.m. June 17, 2013 - MarketWatch.com
Friday’s biggest gaining and declining stocks 10:45 a.m. Jan. 4, 2013 - Greg Morcroft
Amicus Therapeutics up 11% in premarket 8:52 a.m. Jan. 4, 2013 - Steve Gelsi
Thursday’s movers: Apple ends in red on price cut 6:03 p.m. Dec. 20, 2012 - Sue Chang
Amicus down 45% in premarket 9:44 a.m. Dec. 20, 2012 - Steve Gelsi
Amicus falls 47% in premarket trades 8:52 a.m. Dec. 20, 2012 - Steve Gelsi
Bed Bath shares hurt, Jabil climbs after hours 7:31 p.m. Dec. 19, 2012 - Carla Mozee
Amicus, GlaxoSmithKline say treatment misses goal 6:22 p.m. Dec. 19, 2012 - MarketWatch.com
Amicus Therapeutics shares tumble 49% after hours 5:45 p.m. Dec. 19, 2012 - Carla Mozee
U.S. Hot stocks to watch 7:28 a.m. July 18, 2012 - MarketWatch.com
U.S. may end patents on DNA: report 1:13 p.m. Oct. 30, 2010 - Christopher Hinton
Monday's biggest gaining and declining stocks 4:51 p.m. Oct. 5, 2009 - MarketWatch

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog 10:32 a.m. Aug. 27, 2014 - Zacks.com
Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog 9:49 a.m. Aug. 27, 2014 - Zacks.com
The Biotech Stock With The Best One-Week Performance 2:46 p.m. Aug. 25, 2014 - benzinga.com
Amicus Therapeutics (FOLD) Soars on Fabry Drug Trial Results - Analyst Blog 4:55 p.m. Aug. 21, 2014 - Zacks.com
Perilous Reversal Stock: Amicus Therapeutics (FOLD) 9:45 a.m. Aug. 21, 2014 - TheStreet.com
Amicus Therapeutics (FOLD) Worth Watching: Stock Rises 20.4% - Tale of the Tape 9:39 a.m. Aug. 21, 2014 - Zacks.com
Can the Rally in Amicus Therapeutics (FOLD) Shares Continue? - Tale of the Tape 9:03 a.m. Aug. 21, 2014 - Zacks.com
Amicus Therapeutics' (FOLD) CEO John Crowley on Phase III Fabry Monotherapy Study Results (Transcript) 3:43 p.m. Aug. 20, 2014 - Seeking Alpha
Why Amicus Therapeutics (FOLD) Stock Hit a One-Year High Today 10:29 a.m. Aug. 20, 2014 - TheStreet.com
Stocks Hitting 52-Week Highs 9:15 a.m. Aug. 20, 2014 - benzinga.com
Amicus Fabry disease drug candidate successful in Phase 3 trial 7:27 a.m. Aug. 20, 2014 - Seeking Alpha
Benzinga's Top #PreMarket Gainers 7:10 a.m. Aug. 20, 2014 - benzinga.com
Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win 6:01 a.m. Aug. 20, 2014 - TheStreet.com
Amicus' (FOLD) CEO John Crowley on Q2 2014 Results - Earnings Call Transcript 9:37 p.m. Aug. 7, 2014 - Seeking Alpha
10-Q: AMICUS THERAPEUTICS INC 5:07 p.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Why Amicus Therapeutics (FOLD) Might Surprise This Earnings Season - Tale of the Tape 8:44 a.m. Aug. 6, 2014 - Zacks.com
Amicus (FOLD) Shares March Higher, Can It Continue? - Tale of the Tape 11:11 a.m. July 29, 2014 - Zacks.com
Applied Genetic Technologies Corporation (AGTC) Looks Strong as Stock Surges 15.3% - Tale of the Tape 8:44 a.m. July 28, 2014 - Zacks.com
Agenus Inc. (AGEN) Looks Strong as Stock Surges 11.15% - Tale of the Tape 8:44 a.m. July 25, 2014 - Zacks.com
Amicus Therapeutics (FOLD) Jumps: Stock Rises 7.1% - Tale of the Tape 9:39 a.m. July 24, 2014 - Zacks.com

Clinical Trial Results, Change of Corporate Name, New Products, and Completion of Acquisition - Research Reports on GSK, Amicus, WellPoint, IDEXX and Endo 8:40 a.m. Aug. 25, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012 6:00 a.m. Aug. 20, 2014 - GlobeNewswire
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 8:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Second Quarter 2014 Financial Results and Corporate Updates 4:01 p.m. Aug. 7, 2014 - GlobeNewswire
Amicus Therapeutics to Announce Second Quarter 2014 Financial Results on August 7, 2014 4:01 p.m. July 31, 2014 - GlobeNewswire
Conference Call Schedules, Publication of Study Results, and Public Offer Pricing - Research Reports on Medivation, Keryx, Amicus, AGTC and Clovis 8:50 a.m. July 30, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 7:20 a.m. July 10, 2014 - PR Newswire - PRF
Amicus Therapeutics Analyst Report; Solid Pipeline and Near-term Catalysts by BrokerBank Securities, Inc. 2:55 p.m. July 7, 2014 - PR Newswire - PRF
Study Updates, Market Activity, Preclinical Data, and Oral Presentations - Analyst Notes on Amicus, Conatus, Dicerna, Epizyme and Array 6:30 a.m. July 3, 2014 - PR Newswire - PRF
Amicus Therapeutics Provides Updates and Final Analysis Plan for Phase 3 Fabry Monotherapy Study 012 7:00 a.m. June 30, 2014 - GlobeNewswire
Technical Coverage on Top Gainers -- Research on Fresh Market, First Bancorp, Amicus Therapeutics, and Magellan Petroleum 8:20 a.m. June 4, 2014 - PR Newswire - PRF
Amicus Therapeutics to Present at UBS Global Healthcare Conference 4:10 p.m. May 14, 2014 - GlobeNewswire
Amicus Therapeutics Announces First Quarter 2014 Financial Results and Corporate Updates 4:01 p.m. May 5, 2014 - GlobeNewswire
Dr. Farzad Mostashari to keynote SAS Health Analytics Executive Conference 10:30 a.m. May 5, 2014 - BusinessWire - BZX
Positive Data, Financial Results, and Drug Development Programs - Analyst Notes on Novavax, Ironwood, XOMA, Luminex and Amicus 8:00 a.m. May 2, 2014 - PR Newswire - PRF
Amicus Therapeutics to Announce First Quarter 2014 10:01 a.m. May 1, 2014 - GlobeNewswire
Morning Review on Top Gainers -- Research on Banco Santander Brasil, Novavax, Cadence Design Systems, and Amicus Therapeutics 8:00 a.m. April 30, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Positive 12- and 24-Month Data From Phase 3 Fabry Monotherapy Study 011 6:01 a.m. April 29, 2014 - GlobeNewswire
Amicus Therapeutics to Present at 13th Annual Needham Healthcare Conference 4:39 p.m. March 27, 2014 - GlobeNewswire
Amicus Therapeutics Announces Full-Year 2013 Financial Results and Corporate Updates 5:01 p.m. March 3, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Global Vineyards List: New Entrants & Rankings Unveiled

Vineyards' Global Ranking Unveiled Wine enthusiasts and globetrotters have something to toast about this November. The 50 Best Vineyards just expanded its ranking to reveal the vineyards sitting in spots 51 through 100 for 2026. This list, spotlighting some of the globe's finest wine destinations, precedes the main awards ceremony set for November 18 in Santiago, Chile....

Family-Run Pet Retailer Debuts in Alamo Ranch

Pet Supplies Plus Opens Its Doors in Alamo Ranch A fresh wave of pet-centered enthusiasm hit Alamo Ranch as Ray and Naz, proud local entrepreneurs, unveiled their new Pet Supplies Plus store on October 23. This isn't just any run-of-the-mill pet supply shop; it's a reflection of their personal journey as devoted pet parents. With a blend of grit and community spirit,...

Onodrim Raises $300M to Propel EU Defence Future

Onodrim Industries' Bold Bid to Reshape European Security Right out of the gate, Onodrim Industries is thundering onto the scene with a hefty $300 million Series A round to flex its muscles across Europe's defence and industrial sectors. This ain't your run-of-the-mill startup story. This is about flexing hard-earned capital to snap up established players and inject a...

Middleby Under Scrutiny: Shareholder Investigation Alert

Middleby Shareholders in the Crosshairs There's hot soup boiling over at The Middleby Corporation (NASDAQ: MIDD). A shareholder investigation is underway, spearheaded by Purcell & Lefkowitz LLP, a firm that jumps into the fray when there’s a whiff of fiduciary breaches in corporate dealings. As I see it, this kind of legal sniffing around often stirs the pot—raising...

Edgewise Therapeutics' Investor Play: What's the Buzz?

Edgewise Therapeutics Maps Out Investor Terrain Alright, Edgewise Therapeutics, folks. They're shaking things up, and I mean that literally and figuratively. This clinical-stage cardiac biotech isn’t just sitting on its hands; they're out there hustling at the Guggenheim 3rd Annual Healthcare Innovation Conference. Buckle up, because the heart of their...

California Credit Union's Toy Drive Brings Holiday Cheer

California Credit Union Joins Forces for Holiday Toy Drive Alright, folks, here’s a story with a feel-good spin straight out of Glendale. California Credit Union is at it again, teaming up with the Los Angeles Boys & Girls Club to sprinkle some holiday magic on local kiddos and their families. Now, it’s the sixth year straight they’ve pulled off this toy drive...

Weinberger Law Group Secures Top Tier Family Law Ranking

A Testament to Legal Mastery: Weinberger's Latest Accolade In the crowded field of family law, standing out takes more than legal chops. Services have to resonate deeply with the real-life messiness of people's lives. That's what makes Weinberger Divorce & Family Law Group's ranking on the 2027 Best Law Firms® list a real feather in their cap. They're holding down Tier 1...

Gildan Faces Class Action Over Alleged Market Missteps

Legal Storm Brews Over Gildan's Securities Conduct Listen, investors are no strangers to turbulence. But when a company's integrity takes a nosedive, that's when things get precarious fast. Gildan Activewear Inc. (NYSE: GIL) finds itself neck-deep in legal trouble, thanks to alleged securities law violations. On November 9, 2026, DJS Law Group got the ball rolling on a...

Xiaomi's Smart Auto Factory Draws Global Media Praise

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Empyrean Eases Public Sector Benefits with OMNIA Deal

In a world where bureaucratic red tape often chokes efficiency, Empyrean throws a lifeline to public sector bodies. They've nabbed a cooperative purchasing contract with OMNIA Partners, dialing down the procurement guts to make benefits administration easier for government and education folks. Streamlining Public Sector Procurement Public sector organizations ain't...